Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NPO Petrovax Pharm LLC

Latest From Bausch & Lomb Surgical

Cataract and Refractive Surgery: Hoping For a Rebound

April's annual meeting of the American Society of Cataract and Refractive Surgery took place against of the darkest market backdrops in memory. The mood at ASCRS was not all gloom and doom, however. Cataract and refractive surgery technology continues to advance and a number of new product were introduced at the meeting.
Medical Device

Refractec Inc.

Refractec hopes to offer a low-cost alternative to LASIK, a new, non-laser treatment for the underserved group of patients that suffers from farsightedness or hyperopia.
Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Immune Disorders
  • Infectious & Viral Diseases
  • Alias(es)
  • Petrovax Pharm
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Eastern Europe
        • Russia
  • Parent & Subsidiaries
  • NPO Petrovax Pharm LLC
  • Senior Management
  • Andrey Kalashnikov, Strategic Dev. Dir.
    Oleg Rukevich, Sales & Mktg. Dir.
    Arkady Nekrasov, General Dir.
  • Contact Info
  • NPO Petrovax Pharm LLC
    Phone: (7) 495 984 27 53
    2 Dnepropetrovskaya St, 4th Fl.
    Ste. B 4/4
    Moscow, 115598